Two phase III trials of bimekizumab for the treatment of moderate-to-severe hidradenitis suppurativa: a critically appraised research paper

Rebecca McCarthy, Hans Christian Ring

Open source

DOI
10.1093/bjd/ljag051
Published
2026-02-13
Container
British Journal of Dermatology
Publisher
Oxford University Press (OUP)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/bjd/ljag051,
  title = {Two phase III trials of bimekizumab for the treatment of moderate-to-severe hidradenitis suppurativa: a critically appraised research paper},
  author = {Rebecca McCarthy and Hans Christian Ring},
  year = {2026},
  journal = {British Journal of Dermatology},
  doi = {10.1093/bjd/ljag051},
  url = {https://doi.org/10.1093/bjd/ljag051}
}

RIS

TY  - JOUR
TI  - Two phase III trials of bimekizumab for the treatment of moderate-to-severe hidradenitis suppurativa: a critically appraised research paper
AU  - Rebecca McCarthy
AU  - Hans Christian Ring
PY  - 2026
JO  - British Journal of Dermatology
DO  - 10.1093/bjd/ljag051
UR  - https://doi.org/10.1093/bjd/ljag051
ER  - 

APA

McCarthy, R., & Ring, H. C. (2026). Two phase III trials of bimekizumab for the treatment of moderate-to-severe hidradenitis suppurativa: a critically appraised research paper. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljag051

Source records